没食子酸
顺铂
细胞凋亡
体内
药理学
化学
IC50型
抗氧化剂
体外
生物化学
医学
生物
化疗
内科学
生物技术
作者
Miki Kawada,Yasushi Ohno,Yunmo Ri,Tetsuro Ikoma,Hideyuki Yuugetu,Toshihiro Asai,Motohiro WATANABE,Norio Yasuda,Seigou Akao,Genzou Takemura,Shinya Minatoguchi,Kohshi Gotoh,Hisayoshi Fujiwara,Kazunori Fukuda
出处
期刊:Anti-Cancer Drugs
[Lippincott Williams & Wilkins]
日期:2001-11-01
卷期号:12 (10): 847-852
被引量:182
标识
DOI:10.1097/00001813-200111000-00009
摘要
We previously reported that gallic acid (3,4,5-trihydroxybenzoic acid), a naturally occurring plant phenol, can induce apoptosis in four kinds of human lung cancer cell lines in vitro. The present study further investigated the in vivo anti-tumor effects of orally administered gallic acid. Gallic acid reduced cell viability of LL-2 mouse lung cancer cells in vitro dose dependently, with a 50% inhibitory concentration (IC50) value of around 200 microM. C57Black mice were transplanted with LL-2 cells, and administered gallic acid (1 mg/ml in drinking water, ad libitum) and/or cisplatin (4 mg/kg i.p. injection, once a week). The average weight of the transplanted tumors, obtained at 29 days after transplantation, in the mice of control, gallic acid-treated cisplatin-treated and cisplatin plus gallic acid-treated groups was 4.02, 3.65, 3.19 and 1.72 g, respectively. The average tumor weight of the mice treated with cisplatin combined with gallic acid was significantly smaller than that of the control group (p<0.05). The amount of apoptotic cells in the tumor tissues of mice treated with gallic acid and/or cisplatin was significantly higher than those of the control mice. Combination of gallic acid and cisplatin increased the tumor cell apoptosis compared with the treatment with cisplatin alone. The present findings suggest that the combination of gallic acid with an anti-cancer drug, including cisplatin, may be an effective protocol for lung cancer therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI